- RecruitingPHASE3
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
This study looks at a new medicine, NNC0487-0111, for people with heart failure and obesity. It compares the medicine to a dummy treatment (placebo) to see if it's safe and helps improve heart health.
For: Obesity · Heart FailureUnited States · Argentina · Australia - RecruitingPHASE3
AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain
This study looks at a new medicine, NNC0487-0111, for people who are overweight and have knee pain from arthritis. It wants to see if this medicine helps with losing weight and reducing pain compared to a dummy medicine.
For: Obesity · Overweight · Osteoarthritis, KneeUnited States · Australia · Bulgaria - Active not recruitingPHASE3
AMAZE 12: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Maintain Their Weight Loss
This study is looking into a new medicine, NNC0487-0111, to help people who have lost weight keep it off. Participants will get either the new medicine or a dummy medicine by injection once a week to see if it's safe and effective for weight management.
For: ObesityUnited States · Argentina · Australia - RecruitingPHASE3
AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea
This study looks at a new medicine, NNC0487-0111, for people who are overweight or obese and have sleep apnoea. We want to see if it helps with weight loss and improves sleep apnoea. Participants will take weekly injections, either the new medicine or a dummy medicine.
For: Obesity · Overweight · Obstructive Sleep ApnoeaUnited States · Australia · China - RecruitingPHASE1
A Research Study Looking at How NNC0487-0111 Affects Food Intake, Appetite and Metabolism After Meals in People With Obesity
This study looks at how a new medicine, NNC0487-0111, affects how much people with obesity eat, their appetite, and how their bodies use food after meals. Participants will get either the new medicine or a dummy injection, given once a week under the skin.
For: ObesityGermany - RecruitingPHASE1
Investigating How NNC0487-0111 Regulates Insulin of Adults With Type 2 Diabetes
This study looks at a new medicine, NNC0487-0111, for adults with Type 2 diabetes. It aims to understand how this medicine affects how your body uses insulin and how well your pancreas works to control blood sugar.
For: Diabetes MellitusGermany - RecruitingPHASE3
AMAZE 1: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Lose Weight
This study, AMAZE 1, is testing a new medicine called NNC0487-0111 to see if it helps people with excess body weight lose weight. It involves weekly injections, with some participants receiving the active medicine and others a dummy treatment (placebo).
For: ObesityUnited States · Argentina · Australia